Sambi Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 6.10 M
as on 12-12-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 12-12-2024
- Revenue -93.21%
(FY 2023)
- Profit -172.10%
(FY 2023)
- Ebitda -100.32%
(FY 2023)
- Net Worth -9.67%
(FY 2023)
- Total Assets -9.75%
(FY 2023)
About Sambi Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Venkat Sambi, Madhavi Sambireddy, Krishnareddy Sambireddy, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24290TG2021PTC147862
- Company No.
147862
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sambi Life Sciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandesh Korandla  | Director | 19-Jan-2021 | Current |
| Venkat Sambi | Director | 19-Jan-2021 | Current |
| Madhavi Sambireddy | Director | 19-Jan-2021 | Current |
| Krishnareddy Sambireddy | Director | 19-Jan-2021 | Current |
| Hanmanth Reddy | Director | 19-Jan-2021 | Current |
Financial Performance of Sambi Life Sciences.
Sambi Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 93.21% decrease. The company also saw a substantial fall in profitability, with a 172.1% decrease in profit. The company's net worth dipped by a decrease of 9.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sambi Life Sciences?
Unlock access to Sambi Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sambi Pharma Private LimitedActive 5 years 8 monthsVenkat Sambi, Madhavi Sambireddy and 3 more are mutual person
- Mn Gachibowli Ii Tech Park Private LimitedActive 14 years 9 months
Venkat Sambi and Hanmanth Reddy are mutual person
- Sambtek Forex LimitedActive 26 years 11 months
Venkat Sambi, Madhavi Sambireddy and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 17 Jun 2021 | ₹2.00 Cr | Open |
How Many Employees Work at Sambi Life Sciences?
Sambi Life Sciences has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sambi Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sambi Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
